United States · FDA National Drug Code directory

Amlodipine and Olmesartan Medoxomil

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68462-566_6de4a776-9973-4410-ae04-99544813d920
Product NDC
68462-566
Form
TABLET, FILM COATED
Composition / generic term
Amlodipine and Olmesartan Medoxomil
Labeler
Glenmark Pharmaceuticals Inc., USA
Marketing category
ANDA
Marketing start / end (source format)
20170705
Source listing expiry
20261231

Source-listed ingredients

  • AMLODIPINE BESYLATE — 5 mg/1
  • OLMESARTAN MEDOXOMIL — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (68462-566-14) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 68462-566-14
  • 30 TABLET, FILM COATED in 1 BOTTLE (68462-566-30) · 68462-566-30
  • 90 TABLET, FILM COATED in 1 BOTTLE (68462-566-90) · 68462-566-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →